Sermorelin Acetate Injectable Recalled Due to Lack of Sterility Assurance
Carolina Infusion is recalling Sermorelin Acetate injectable (1 MG/ML, 9 ML syringes) distributed nationwide due to lack of assurance of sterility. The manufacturer could not adequately document that the product meets required sterility standards.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is a high-risk product (injectable medication) with a confirmed manufacturing issue (lack of sterility assurance), but no reported illnesses or injuries. Per the rubric, risk-of-harm products where injury has not yet been reported are scored as High.
Plain-English summary
Carolina Infusion is recalling Sermorelin Acetate 1 MG/ML Injectable supplied in 9 ML syringes due to lack of assurance of sterility. The affected lots are 08012022@14 (BUD 08/31/2022) and 08192022@7 (BUD 09/23/2022).
Injectable medications must meet strict sterility standards to be safe for use. This product does not have adequate documentation demonstrating that it meets those standards. The manufacturer could not provide sufficient assurance of the product's sterility.
The recalled product was distributed nationwide in the United States. Patients or healthcare facilities with this product should contact their pharmacist or healthcare provider. Consumers should not use the remaining product without consulting a healthcare professional.
The recalled product
- Product
- Sermorelin Acetate 1 MG/ML Injectable, 9 ML syringes, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936.
- Manufacturer
- Carolina Infusion
- Category
- Drug — Injectable
- Hazard
- sterility-failure
- contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lots: 08012022@14 BUD: 08/31/2022
- 08192022@7 BUD: 09/23/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27